Blood Cancer

Blood Cancer
Haematology

Haematology is the study of blood, blood diseases, and blood-forming tissues and organs. Haematologists focus on the diagnosis, treatment and prevention of blood-related disorders and malignancies. They also focus on diseases of the bone marrow and lymphatic organs such as the lymph node, thymus, spleen, and tonsils which are fed by blood cells and are crucial for the body’s immune response.2

For over three decades, Janssen has dedicated itself to advancing research and solutions to meet the needs of people with haematological malignancies. Our goal is to not only make blood-related conditions treatable, but ultimately preventable and curable.3

Explore our Disease Areas

Waldenström's Macroglobulinemia (WM)

Waldenström's Macroglobulinemia is a rare and slow-growing cancer of the white blood cells. It mostly grows in the bone marrow, slowing down the growth of blood cells which can lead to anaemia and a weakened immune system.4

Amyloidosis

Amyloidosis occurs when the body begins to make a protein differently than it did before and is no longer able to absorb that protein.5 There are several types of Amyloidosis, the four most common of which are: Amyloid light-chain (AL) Amyloidosis, Amyloid A (AA) Amyloidosis, Hereditary Amyloidosis, and Wild-type Amyloidosis.6

Chronic Lymphocytic Leukaemia (CLL)

Chronic Lymphocytic Leukaemia is a slow-growing cancer of the blood and bone marrow, which results in incompetent, small white blood cells that compromise the immune system. CLL is one of the most common types of leukaemia in Western countries, accounting for 25% of all diagnoses.6 There are instances in which CLL is used as an overarching term that includes Small Lymphocytic Lymphoma (SLL) because they are both nearly the same disease, however CLL is commonly detected in the blood and bone marrow, whereas SLL is primarily detected in the lymph nodes.

Mantle Cell Lymphoma (MCL)

Mantle Cell Lymphoma is an aggressive type of blood cancer that develops in the outer part of the lymph node, an essential part of the immune system.7 Affecting only 1 in 100,000 people, MCL is a very rare cancer.8

Multiple myeloma (MM)

Multiple Myeloma is a rare, slow-growing cancer of the white blood cells that weakens the immune system and inhibits important organs from functioning.9 In those with MM, mutated white blood cells last longer and multiply rapidly, taking up space in the bloodstream and crowding out healthy cells.9

References

Myeloma UK. Infopack for carers of myeloma patients. Available at: http://www.myeloma.org.uk/wp-content/uploads/2018/03/Myeloma-UK-An-Infopack-for-carers-of-myeloma-patients.pdf. Last accessed April 2021.